Impact of COVID-19 pandemic on central-line-associated bloodstream infections during the early months of 2020, National Healthcare Safety Network.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 16 3 2021
medline: 10 6 2022
entrez: 15 3 2021
Statut: ppublish

Résumé

Data reported to the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC NHSN) were analyzed to understand the potential impact of the COVID-19 pandemic on central-line-associated bloodstream infections (CLABSIs) in acute-care hospitals. Descriptive analysis of the standardized infection ratio (SIR) was conducted by location, location type, geographic area, and bed size.

Identifiants

pubmed: 33719981
pii: S0899823X21001082
doi: 10.1017/ice.2021.108
pmc: PMC8047389
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

790-793

Auteurs

Prachi R Patel (PR)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
CACI, Atlanta, Georgia.

Lindsey M Weiner-Lastinger (LM)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Margaret A Dudeck (MA)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Lucy V Fike (LV)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

David T Kuhar (DT)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Jonathan R Edwards (JR)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Daniel Pollock (D)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Andrea Benin (A)

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH